We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+0.07%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$740M
AUM Growth
-$26.6M
Cap. Flow
-$11.6M
Cap. Flow %
-1.57%
Top 10 Hldgs %
45.11%
Holding
310
New
89
Increased
45
Reduced
51
Closed
109

Top Buys

Rank Stock Value
1
USB icon
US Bancorp
USB
+$16M
2
MRSH
Marsh
MRSH
+$9.63M
3
GS icon
Goldman Sachs
GS
+$8.1M
4
APG icon
APi Group
APG
+$7.73M
5
MBAC
M3-Brigade Acquisition II Corp.
MBAC
+$7.36M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$9.96M
2
DNLI icon
Denali Therapeutics
DNLI
+$9.75M
3
TRV icon
Travelers Companies
TRV
+$9.3M
4
BLDR icon
Builders FirstSource
BLDR
+$8.41M
5
SAH icon
Sonic Automotive
SAH
+$6.87M

Sector Composition

Rank Sector Weight
1 Healthcare 33.59%
2 Financials 26.36%
3 Technology 13.34%
4 Industrials 9.39%
5 Materials 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CABA icon
201
Cabaletta Bio
CABA
$437M
$14K ﹤0.01%
21,881
– –
ACDC icon
202
ProFrac Holding
ACDC
$731M
– –
-35,000
Closed -$641K
ADAP
203
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-39,489
Closed -$67K
ADVM
204
DELISTED
Adverum Biotechnologies
ADVM
– –
-6,485
Closed -$78K
AFG icon
205
American Financial Group
AFG
$11.8B
– –
-30,000
Closed -$4.16M
AFL icon
206
Aflac
AFL
$64.9B
– –
-60,000
Closed -$3.32M
AMP icon
207
Ameriprise Financial
AMP
$48.3B
– –
-5,000
Closed -$1.19M
ANSS
208
DELISTED
Ansys
ANSS
– –
-5,979
Closed -$1.43M
APRE icon
209
Aprea Therapeutics
APRE
$7.68M
– –
-2,441
Closed -$36K
ARLP icon
210
Alliance Resource Partners
ARLP
$3.34B
– –
-191,839
Closed -$3.5M
ASMB icon
211
Assembly Biosciences
ASMB
$498M
– –
-3,543
Closed -$89K
AXP icon
212
American Express
AXP
$227B
– –
-46,000
Closed -$6.38M
BAC icon
213
Bank of America
BAC
$435B
– –
-320,000
Closed -$9.96M
BHP icon
214
BHP
BHP
$215B
– –
-20,500
Closed -$1.15M
BIIB icon
215
Biogen
BIIB
$30B
– –
-9,595
Closed -$1.96M
BRK.B icon
216
Berkshire Hathaway Class B
BRK.B
$1.1T
– –
-5,000
Closed -$1.36M
CADE
217
DELISTED
Cadence Bank
CADE
– –
-215,000
Closed -$5.05M
CCJ icon
218
Cameco
CCJ
$37.6B
– –
-187,200
Closed -$3.94M
CCK icon
219
Crown Holdings
CCK
$12.8B
– –
-46,780
Closed -$4.31M
CGAU
220
Centerra Gold
CGAU
$3.36B
– –
-288,985
Closed -$1.96M
CHWY icon
221
Chewy
CHWY
$9.25B
– –
-20,000
Closed -$694K
CLX icon
222
Clorox
CLX
$11.6B
– –
-4,000
Closed -$564K
CMC icon
223
Commercial Metals
CMC
$7.6B
– –
-139,789
Closed -$4.63M
CME icon
224
CME Group
CME
$96.3B
– –
-27,000
Closed -$5.53M
CMG icon
225
Chipotle Mexican Grill
CMG
$47.2B
– –
-87,500
Closed -$2.29M
7 8
9
10 11

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q3 2022 Portfolio in Review

As of Q3 2022, Crestline Management held 310 positions worth $740M, down 3.5% from $766M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Crestline Management's Q3 2022 filing shows 89 new, 45 increased, 51 reduced and 109 closed positions. Its largest new stake was US Bancorp: 345,000 shares worth $13.9M. The largest sale was Bank of America, an estimated $9.96M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Financials and Technology.

  • Crestline Management's largest Q3 2022 buy was US Bancorp: 345,000 shares worth $13.9M.
  • Crestline Management added most to NCR Voyix in Q3 2022, an estimated $6.86M increase.
  • Crestline Management's biggest Q3 2022 reduction was Denali Therapeutics, cutting an estimated $9.75M.
  • Crestline Management fully exited Bank of America in Q3 2022, selling an estimated $9.96M.
  • Crestline Management's ten largest holdings make up 45% of its $740M portfolio in Q3 2022.
  • Crestline Management opened 89 new positions and closed 109 in Q3 2022.
  • Crestline Management's portfolio value fell 3.5% quarter-over-quarter to $740M.

Based on Crestline Management's 13F filing for Q3 2022, filed 14 Nov 2022.